Mavenclad
NDC Package 44087-6000-5
Package Information
Mavenclad is cladribine is used to treat relapsing forms of multiple sclerosis (MS). Marketed by Emd Serono, Inc., this product is identified by NDC 44087-6000 and is authorized under FDA application NDA022561.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 44087 - Emd Serono, Inc.
- 44087-6000 - Mavenclad
- 44087-6000-5 - 5 BLISTER PACK in 1 CARTON / 1 TABLET in 1 BLISTER PACK
- 44087-6000 - Mavenclad
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (44087-6000). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 44087-6000-5 identifies a specific commercial package of 5 blister pack in 1 carton / 1 tablet in 1 blister pack of Mavenclad, labeled by Emd Serono, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Emd Serono, Inc. on March 29, 2019. The current certification is valid through March 29, 2019.
What are the primary indications for this medication?
Cladribine is used to treat relapsing forms of multiple sclerosis (MS). It is not a cure for MS but it is thought to help by preventing immune system cells (lymphocytes) from attacking the nerves in your brain and spinal cord. It may help to slow disease worsening and decrease flare-ups of symptoms.
How is this Emd Serono, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 44087600005. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.
